Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
Timothy R. Abbott(Stanford University), Girija Dhamdhere(Stanford University), Yanxia Liu(Stanford University), Xueqiu Lin(Stanford University), Laine Goudy(Stanford University), Leiping Zeng(Stanford University), Augustine Chemparathy(Stanford University), Steven A. Chmura(DNARx (United States)), Nicholas S. Heaton(Duke University), Robert J. Debs(DNARx (United States)), Tara Pande, Drew Endy(Stanford University), Marie La Russa(Stanford University), David B. Lewis(Stanford Medicine), Lei S. Qi(Stanford University)
Cited by 503Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis